Study of plasma concentration of Imatinib in Chinese patients with gastrointestinal stromal tumor

Trial Profile

Study of plasma concentration of Imatinib in Chinese patients with gastrointestinal stromal tumor

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 May 2017

At a glance

  • Drugs Imatinib (Primary)
  • Indications Gastrointestinal stromal tumours
  • Focus Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 30 Apr 2017 Status changed from not yet recruiting to completed.
    • 22 Apr 2016 Planned End Date changed from 1 Jun 2016 to 1 Sep 2016.
    • 22 Apr 2016 Phase of the study is changed from phase I to phase IV.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top